OXUR.BR
Oxurion NV
Price:  
0.07 
EUR
Volume:  
33,026.00
Belgium | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OXUR.BR WACC - Weighted Average Cost of Capital

The WACC of Oxurion NV (OXUR.BR) is 6.0%.

The Cost of Equity of Oxurion NV (OXUR.BR) is 17.70%.
The Cost of Debt of Oxurion NV (OXUR.BR) is 5.60%.

Range Selected
Cost of equity 4.10% - 31.30% 17.70%
Tax rate -% - -% -%
Cost of debt 4.00% - 7.20% 5.60%
WACC 4.0% - 7.9% 6.0%
WACC

OXUR.BR WACC calculation

Category Low High
Long-term bond rate 2.9% 3.4%
Equity market risk premium 6.0% 7.0%
Adjusted beta -0.88 3
Additional risk adjustments 6.5% 7.0%
Cost of equity 4.10% 31.30%
Tax rate -% -%
Debt/Equity ratio 30.62 30.62
Cost of debt 4.00% 7.20%
After-tax WACC 4.0% 7.9%
Selected WACC 6.0%

OXUR.BR's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for OXUR.BR:

cost_of_equity (17.70%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (-0.88) + risk_adjustments (6.75%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.